Cargando...
Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells
The Bruton's tyrosine kinase (BTK) inhibitor ibrutinib is effective in the treatment of human chronic lymphocytic leukaemia and mantle cell lymphoma. Recent data have shown that ibrutinib also blocks IgE‐dependent activation and histamine release in human basophils (BAs) and mast cells (MCs). T...
Gardado en:
| Publicado en: | Vet Comp Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Blackwell Publishing Ltd
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6900099/ https://ncbi.nlm.nih.gov/pubmed/31286638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vco.12520 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|